Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436266 · ClinicalTrials.gov registry record · Phase 3
Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion
A Phase 3 study, sponsored by Boston University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT01436266 is a Phase 3 study that was terminated before completion, run by Boston University. The registered enrollment target is 3 participants.
The verdict
NCT01436266, a Phase 3 study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
Misoprostol is a medication used extensively in obstetrics and gynecology for its ability to aid in softening the cervix as well as decreasing blood loss after abortion or vaginal delivery. Opinions vary as to its usefulness in aiding in cervical dilation, and in decreasing blood loss. The investigators propose to conduct a randomized, placebo-controlled trial to evaluate whether misoprostol given buccally 2 hours prior to second trimester surgical abortion decreases blood loss from the procedure. The investigators will also assess whether misoprostol improves cervical dilation, changes the length of the procedure, changes the need for additional mechanical dilation, changes the subjective ease of the procedure, and changes a woman's pain.
Interventions
- DRUG Misoprostol
- OTHER Folic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01436266
The ClinicalTrials.gov registry entry for NCT01436266 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Misoprostol is the first listed.
NCT01436266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01436266 about?
NCT01436266 is a clinical study titled "Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion". Misoprostol is a medication used extensively in obstetrics and gynecology for its ability to aid in softening the cervix as well as decreasing blood loss after abortion or vaginal delivery. Opinions vary as to its usefulness in aiding in cervical dilation, and in decreasing blood loss. The investiga...
What is the current status of trial NCT01436266?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2011-07. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01436266?
The interventions under investigation include: Misoprostol (DRUG), Folic acid (OTHER).
Who is sponsoring clinical trial NCT01436266?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.